Skip to search formSkip to main contentSkip to account menu

Leishmaniasis, Cutaneous

Known as: leishmaniasis cutaneous, Cutaneous Leishmaniasis, Cutaneous Leishmaniases 
An endemic disease that is characterized by the development of single or multiple localized lesions on exposed areas of skin that typically ulcerate… 
National Institutes of Health

Related topics

Related topics

14 relations
Chiclero ulcerIn BloodIntegumentary systemLeishmania tropica

Broader (1)

Leishmaniasis

Narrower (2)

Leishmaniasis, New WorldUrban cutaneous leishmaniasis

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
2011
Highly Cited
2011
Leishmania major infection among Psammomys obesus and Meriones shawi: reservoirs of zoonotic cutaneous leishmaniasis in Sidi Bouzid(central Tunisia).
A study was undertaken between November 2008 and March 2010, in the focus of cutaneous leishmaniasis of Central Tunisia, to… 
Highly Cited
2002
Highly Cited
2002
Treatment of cutaneous leishmaniasis with a topical antileishmanial drug (WR279396): phase 2 pilot study.
We studied the efficacy of WR279396, a topical formulation of aminoglycosides that cures 100% of cutaneous leishmaniasis lesions… 
Review
1997
Review
1997
Inefficacy of Allopurinol as Monotherapy for Colombian Cutaneous Leishmaniasis
New World cutaneous leishmaniasis classically presents as an ulcerating papule or nodule. The ulcer then reepithelializes during… 
Highly Cited
1993
Highly Cited
1993
Determination of the cytokine profile in American cutaneous leishmaniasis using the polymerase chain reaction
The lymphokine profiles were determined in the skin lesions of the three distinct clinical forms of American cutaneous… 
Highly Cited
1993
Highly Cited
1993
The Role of Interferon-γ in the Treatment of Visceral and Diffuse Cutaneous Leishmaniasis
Traditionally, the mainstay of visceral and diffuse cutaneous leishmaniasis therapy has been pentavalent antimony, with… 
Highly Cited
1987
Highly Cited
1987
Lipophosphoglycan of Leishmania major that vaccinates against cutaneous leishmaniasis contains an alkylglycerophosphoinositol lipid anchor.
The major cell surface glycoconjugate of Leishmania major, a putative parasite receptor for macrophages, is a lipophosphoglycan… 
Highly Cited
1986
Highly Cited
1986
Controlled field trials of a vaccine against New World cutaneous leishmaniasis.
Two controlled, double blind field trials of a non-living promastigote vaccine against New World Cutaneous Leishmaniasis (NWCL… 
Highly Cited
1985
Highly Cited
1985
In situ characterization of the cellular immune response in American cutaneous leishmaniasis.
American cutaneous leishmaniasis is a spectrum of granulomatous disease caused by related species of an intracellular parasite… 
Highly Cited
1984
Highly Cited
1984
Exacerbation of murine cutaneous leishmaniasis by adoptive transfer of parasite-specific helper T cell populations capable of mediating Leishmania major-specific delayed-type hypersensitivity.
The effect of adoptive transfer of in vitro-propagated Leishmania major-specific T cell populations on the course of… 
Highly Cited
1983
Highly Cited
1983
Effectiveness of leishmanization in the control of cutaneous leishmaniasis.
To find out the effectiveness of leishmanization in the control of zoonotic cutaneous leishmaniasis, more than 250 persons were… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)